This article documents four cold sore cases tracked at three timepoints: day zero (active outbreak), 48 hours into treatment, and 120 hours (day five). All four cases used the Labisan dual protocol: 22:1 graviola fruit-extract capsules taken systemically and Labisan Protective Lip Balm applied topically four times per day. The cases cover four anatomical sites (lips, upper back, inner thigh, cheek) and four lifestyle triggers, and they cover both HSV-1 (the strain most people associate with oral cold sores or fever blisters) and HSV-2 (the strain more commonly associated with skin and genital presentations). The intent is honest documentation of what the dual protocol looks like across a realistic 5-day timeline, not a marketing flourish. Recovery was not "instant" in any case. It was steady, with visible day-by-day progression.
The wider word index for the same condition: cold sore, fever blister, oral herpes, herpes labialis, herpes simplex, HSV outbreak, lip blister, mouth ulcer (when on the lip border). Search behaviour clusters around "cold sore" by a wide margin, but the underlying virology is the same, and the protocol described below is calibrated against the typical 7 to 10 day natural course of an untreated outbreak.
Why Two Products: The Topical and Systemic Layers
A cold sore outbreak has two layers happening simultaneously. The first layer is virus replicating on or near the surface of the affected skin or mucosa, where topical antivirals can act directly. The second layer is the immune response in the surrounding tissue and the broader systemic inflammatory state, which is what determines how fast the lesion resolves and whether the next outbreak hits sooner or later.
The Labisan Protective Lip Balm handles the topical layer. Its full formula is documented in the lip balm formula breakdown. The five-active stack (22 percent non-nano zinc oxide, 5 percent graviola fruit extract, manuka oil, oregano oil with carvacrol and thymol, menthol) attacks the surface viral replication and accelerates the local healing process. The supporting layer of astaxanthin, vitamin E, and allantoin handles the antioxidant and tissue-regeneration side.
The Labisan Graviola Capsules handle the systemic layer. The 22:1 water extract from the fruit of Annona muricata delivers the polyphenol, flavonoid, and milder acetogenin fraction through digestion to the circulating immune tissue. The fruit vs leaf extract safety post covers why fruit extract specifically is the source tissue for the capsule. The combination is the dual protocol: topical actives on the lesion surface, systemic actives on the immune response surrounding it.
Case 1: Lips, Male, Alpine Ski Trip Trigger
Subject: man, late thirties, weather-tanned outdoor complexion. Trigger: third day of a ski trip in the Alps. Cold dry air, high altitude UV exposure (UV index roughly 30 percent higher than at sea level), tired immune system from sleep debt and physical exertion. Stage at day zero: full HSV-1 outbreak, vesicle cluster across the lower lip with visible crusting at the lesion edges and surrounding redness. The classic alpine cold sore presentation.
Protocol: Labisan Protective Lip Balm applied four times per day at four-hour intervals during waking, plus 4 graviola capsules per day (the elevated outbreak dose, see the prevention vs early outbreak post) for the first three days, then back to baseline 3 capsules per day from day three onward.
Outcome: at 48 hours the active vesicles had dried and a small scab had formed, with surrounding redness visibly reduced. By day five (120 hours) the scab had shed and only a faint pink residual mark remained. The lip contour was back to normal. Subjective discomfort dropped substantially after the first 24 hours of dual-protocol application, which the formulation team attributes primarily to the menthol and zinc oxide layers in the topical balm.
Case 2: Upper Back, Female, Training and Sleep Stress Trigger
Subject: woman, mid-thirties, fit athletic build, recreational endurance athlete. Trigger: third week of a heavy training block, four to five hours of sleep per night, elevated cortisol, sleep debt accumulating. Stage at day zero: vesicle cluster on the upper back near the right shoulder blade, classic stress-triggered HSV reactivation. This presentation is more often HSV-2 than HSV-1, although either strain can produce dermal lesions outside the typical oral or genital sites.
Protocol: Labisan Protective Lip Balm applied to the back lesion four times per day at four-hour intervals (off-label use on closed skin is appropriate per the formulation team), plus 4 graviola capsules per day for the first three days then back to 3 per day. The user also reduced training volume by roughly half for the five-day window.
Outcome: at 48 hours the vesicles had dried and consolidated into a tighter, smaller crust. The surrounding redness was visibly fading. By 120 hours the crust had shed and only a faint pink residual mark remained on the previously affected area. The user reported significantly improved sleep on day three after restarting the systemic graviola dose, which is consistent with the polyphenol-driven antioxidant load reducing the chronic-stress oxidative burden documented in the chronic stress immune resilience post.
Case 3: Inner Thigh, Male, Trail-Run Friction Trigger
Subject: man, early forties, athletic build, weekend trail runner. Trigger: a 25 kilometre trail run in heat, with friction and sweat in the inner-thigh region creating the precondition for HSV reactivation along a previously latent dermatomal nerve path. Stage at day zero: tight cluster of vesicles on the upper inner thigh skin, away from the genital area, classic HSV-2 dermatomal presentation but possible HSV-1 spread to the same site. Either strain produces the same lesion morphology and responds similarly to the protocol.
Protocol: Labisan Protective Lip Balm applied to the inner-thigh lesion four times per day at four-hour intervals, plus 4 graviola capsules per day for the first three days then back to 3. The user also paused running for the five-day window and avoided clothing that produced friction over the lesion site.
Outcome: at 48 hours the cluster was visibly smaller and partially crusted, with surrounding redness reduced. By 120 hours the crusts had shed and only a faint pink residual remained. No new vesicles appeared during the five-day window. The user resumed light running on day six and full training volume on day eight without recurrence in the following 30 days.
Case 4: Cheek, Female, Travel and Sun Exposure Trigger
Subject: woman, late twenties, fair to medium skin tone with subtle freckling. Trigger: long-haul flight followed by two days of intense sun exposure on a beach holiday with no UV protection on the cheek and lip area. The combination of sleep debt, dehydration, and UV stress reactivated a latent HSV-1 infection at a peri-oral site (on the cheek, just outside the lip border, rather than on the lip itself, which is a common spread pattern).
Protocol: Labisan Protective Lip Balm applied to the cheek lesion four times per day at four-hour intervals, plus 4 graviola capsules per day for the first three days then back to 3. The user also added strict sun avoidance and continued application of the lip balm to the surrounding lip border as a preventive measure during the five-day window.
Outcome: at 48 hours the lesion had consolidated into a smaller crust with reduced surrounding redness. By 120 hours the scab had shed and only a faint pink residual mark remained. The user reported the dual protocol as substantially faster than her usual 8 to 10 day untreated cold sore course based on her own historical pattern.
The Protocol in One Place
Across all four cases the cadence was identical. This is the dual-protocol summary as the formulation team specifies it:
- Topical: Labisan Protective Lip Balm applied four times per day at four-hour intervals during waking hours. On lip lesions, apply directly to the affected area. On non-lip closed-skin lesions, apply the same way directly to the lesion site. Continue for the full five-day window even if visible improvement appears earlier.
- Systemic: Labisan 22:1 Graviola Fruit Capsules at the elevated outbreak dose of 4 capsules per day for the first three days, then return to the baseline 3 capsules per day from day four onward. Take with food. The 8,000mg daily dose post covers the bioactive math behind the baseline dose.
- Lifestyle: reduce or pause training intensity for the five-day window, prioritise sleep, avoid known triggers (UV exposure, friction, alcohol, dietary stress).
The five-day window is not arbitrary. It is the time frame across which the topical zinc oxide, antiviral oils, and graviola fruit extract on the surface, plus the systemic polyphenol and acetogenin layer, can fully accelerate a typical 7 to 10 day natural HSV outbreak course down to roughly half its expected duration. Individual results vary based on lesion stage at start of protocol, immune status, and adherence to the cadence.
HSV-1 vs HSV-2: Why the Same Protocol Works for Both
HSV-1 (herpes simplex virus type 1) is the strain associated with most oral cold sores, fever blisters, and herpes labialis presentations. HSV-2 (herpes simplex virus type 2) is more often associated with genital herpes and is the strain more commonly linked to dermal vesicle clusters on non-oral skin (back, leg, hand). In practice the morphology of the lesion is similar in both cases (small fluid-filled vesicles on an erythematous base, evolving through crust to healing), and the cellular replication mechanism is similar (envelope membrane, intracellular replication, neuronal latency between outbreaks).
The Labisan formula's antiviral mechanism is not strain-specific. The acetogenins in the graviola fruit extract interfere with viral replication through mitochondrial Complex I modulation regardless of which HSV strain is replicating. The beta-triketones in manuka oil and the carvacrol-thymol pair in oregano oil disrupt the viral envelope of either strain. Zinc oxide dries either lesion type. The five-active stack delivers cross-strain coverage, which is why the same protocol works across all four cases above despite different anatomical sites and likely different strain identification.
The Dual Protocol: Topical and Systemic Together
Labisan Protective Lip Balm + Labisan 22:1 Graviola Capsules
Lip Balm Single: $24.99 | Graviola Capsules Single: $44.99
Adventure Pack 3x lip balms: $59.99 | Graviola 3x: $119.97
Free shipping on orders over $49. 30 day money back guarantee.
Shop Lip Balm Shop GraviolaFrequently Asked Questions
Why are cold sores not fully cleared at 48 hours in the photos?
Because that is what an honest 48 hour mark looks like in a real HSV outbreak under active treatment. The protocol does not eliminate the lesion overnight. What it does is consolidate the active vesicle phase into a tight scab faster, reduce surrounding redness, and stop new vesicles from forming. The scab itself sheds over the next two to three days, leaving the residual mark visible in the day-five images. Marketing imagery that shows a "fully cleared" lesion at 48 hours is unrealistic and is one of the reasons most over-the-counter cold sore brands cannot reliably back up their claims with documented timelines.
Is this HSV-1 or HSV-2 in the case studies?
Case 1 (lips) and Case 4 (cheek peri-oral) are most likely HSV-1, the strain associated with the majority of oral and peri-oral cold sores. Case 2 (upper back) and Case 3 (inner thigh) are anatomical sites more commonly associated with HSV-2, although either strain can produce dermal vesicle clusters at any site. Strain identification was not laboratory-confirmed in these cases, which is consistent with how most real outbreaks are managed in the field. The protocol works on either strain because the antiviral mechanism is not strain-specific.
What is the most common search term for this condition?
"Cold sore" is the dominant search term, followed by "fever blister", "herpes simplex", "lip blister", and "oral herpes". All five describe the same underlying condition (HSV-1 reactivation at the lip border or peri-oral skin). The clinical name is herpes labialis when the lesion is on the lip itself.
Can I use the lip balm on body and limb lesions like the case studies?
Yes, the formulation team allows topical use on closed-skin lesions and minor skin irritations beyond the lip border, as discussed in the lip balm formula breakdown. The five-active stack is broadly antiviral and antiseptic, not lip-specific. Avoid use on broken non-lesion skin in children under five and avoid contact with the eyes.
Why 4 graviola capsules during outbreak vs 3 baseline?
The baseline 3 capsules per day delivers roughly 8,000mg of bioactive equivalent, which is the daily preventive dose. During an active outbreak, the elevated 4 capsules per day raises that to roughly 11,000mg of bioactive equivalent for the first three days, which more aggressively supports the immune response while the topical layer handles the surface lesion. After day three the body has the active layer under control and the elevated dose is no longer needed. The prevention vs early outbreak post covers this two-tier dosing in depth.
How does this compare to acyclovir or other antiviral creams?
Acyclovir creams act on a single antiviral mechanism (nucleoside analogue interfering with viral DNA polymerase) and produce documented but modest reductions in lesion duration. The Labisan dual protocol acts on multiple antiviral mechanisms (acetogenin Complex I modulation, beta-triketone envelope disruption, carvacrol-thymol membrane disruption, zinc oxide drying) and adds a systemic immune-support layer through the graviola capsule. The two approaches are not mutually exclusive and the Labisan protocol can be used alongside prescription antivirals where a clinician has recommended them.
The Bottom Line
Four documented cases, four anatomical sites, four lifestyle triggers, one dual protocol. Day 0 outbreak, day 2 active healing with crust formation, day 5 near-complete resolution with only a faint residual mark. The Labisan formula delivers that timeline through five topical actives plus a systemic immune-support layer, applied four times daily on the lesion and taken three to four times daily as a capsule. The five-day window roughly halves the typical 7 to 10 day untreated HSV outbreak course. Individual results depend on lesion stage at start of protocol, immune status, and adherence to the cadence.
Labisan Protective Lip Balm and Labisan 22:1 Graviola Fruit Capsules are manufactured to EU pharmaceutical-grade standards. Free shipping on orders over $49, 30 day money back guarantee.
